"Working with MD Anderson, Monash Uni and the Peter Mac Cancer Institute the company plans to undertake clinical translational development of three programs in its R&D pipeline: the staging of HER2+ breast cancer to minimize use of invasive lymphadenectomy; the primary diagnosis of prostate cancer to reduce the need for prostate biopsy; and the detection of epithelial ovarian carcinoma in women as an alternative to late stage detection by trans-vaginal ultrasound"
http://biomelbourne.org/membership/member-directory/user/1641/
- Forums
- ASX - By Stock
- IBX
- Interesting
Interesting, page-23
-
- There are more pages in this discussion • 5,484 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Exciting new copper-gold discoveries at Tarraji-Yampi: Dive into the strong drilling results now
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.7¢ |
Change
-0.003(7.50%) |
Mkt cap ! $1.318M |
Open | High | Low | Value | Volume |
3.7¢ | 3.8¢ | 3.5¢ | $7.532K | 207.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 40750 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 14800 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 40750 | 0.037 |
2 | 114166 | 0.036 |
2 | 317000 | 0.035 |
1 | 20000 | 0.034 |
2 | 43750 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 14800 | 1 |
0.048 | 13016 | 2 |
0.050 | 155 | 1 |
0.055 | 88714 | 1 |
0.056 | 11703 | 2 |
Last trade - 13.15pm 07/10/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |